Abstract: Provided herein are compositions, methods, and kits for proliferating muscle cells by exposing the muscle cells to a prostaglandin E2 (PGE2) compound or compound that activates PGE2 signaling. Also provided are methods for regenerating muscle in a subject suffering from muscular atrophy, dystrophy, and/or injury by administering a PGE2 compound alone or in combination with isolated muscle cells. The PGE2 compound in combination with the isolated muscle cells can be administered prophylactically to prevent a muscle disease or condition.

Abstract: Provided herein are compositions for preventing or treating muscle conditions such as muscle damage, injury, or atrophy. In some embodiments, the compositions comprise a prostaglandin E2 (PGE2) compound and a myotoxin. In some embodiments, the muscle damage, injury, or atrophy is the result of a nerve injury, a surgical procedure, or a traumatic injury. Methods of promoting muscle regeneration and methods of increasing muscle mass are also provided herein.

Abstract: A method and system for reforming CO2 rich natural gases is disclosed which comprises: a cold plasma unit configured to convert CO2 rich natural gases into a plasma state; and a gas reforming reactor configured to reform said CO2 rich gas mixture at said plasma state into a syngas. The catalytic reforming reactor is separate and different from the DBD cold plasma unit. Means for latent heat of condensation, endothermic/exothermic reactions, and convection currents is used to achieve energy efficiency.

Abstract: Provided herein are compositions for preventing or treating muscle conditions such as muscle damage, injury, or atrophy. In some embodiments, the compositions comprise a prostaglandin E2 (PGE2) compound and a myotoxin. In some embodiments, the muscle damage, injury, or atrophy is the result of a nerve injury, a surgical procedure, or a traumatic injury. Methods of promoting muscle regeneration and methods of increasing muscle mass are also provided herein.

Abstract: A method and system for reforming CO2 rich natural gases is disclosed which comprises: a cold plasma unit configured to convert CO2 rich natural gases into a plasma state; and a gas reforming reactor configured to reform said CO2 rich gas mixture at said plasma state into a syngas. The catalytic reforming reactor is separate and different from the DBD cold plasma unit. Means for latent heat of condensation, endothermic/exothermic reactions, and convection currents is used to achieve energy efficiency.

Abstract: The present disclosure provides compositions and methods based on the identification of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as a therapeutic target in aging, dystrophic muscle to improve muscle atrophy, increase muscle mass, function and strength. Further provided herein are compositions and methods for the rejuvenation of aged tissue. In particular, 15-PGDH inhibitors, such as SW033291, are used to elevate the levels of prostaglandin E2 (PGE2) in the muscle or tissue.

Abstract: Provided herein are compositions for preventing or treating muscle conditions such as muscle damage, injury, or atrophy. In some embodiments, the compositions comprise a prostaglandin E2 (PGE2) compound and a myotoxin. In some embodiments, the muscle damage, injury, or atrophy is the result of a nerve injury, a surgical procedure, or a traumatic injury. Methods of promoting muscle regeneration and methods of increasing muscle mass are also provided herein.

Abstract: A method and system for renewing spent fluid catalytic cracking (SFCC) catalysts are disclosed which comprises: treating SFCC catalysts using a static reactor designed to uniformly distribute with an oxalic acid solution and its reflux to obtain leached SFCC catalysts; washing with aqueous solution and filtering to collect cleaned and treated SFCC catalyst; and c) executing the cleaned and treated SFCC catalyst with thermal treatment to obtain renewed FCC catalysts.

Abstract: Provided herein are compositions, methods, and kits for proliferating muscle cells by exposing the muscle cells to a prostaglandin E2 (PGE2) compound or compound that activates PGE2 signaling. Also provided are methods for regenerating muscle in a subject suffering from muscular atrophy, dystrophy, and/or injury by administering a PGE2 compound alone or in combination with isolated muscle cells. The PGE2 compound in combination with the isolated muscle cells can be administered prophylactically to prevent a muscle disease or condition.

Abstract: Provided herein are compositions, methods, and kits for proliferating muscle cells by exposing the muscle cells to a prostaglandin E2 (PGE2) compound or compound that activates PGE2 signaling. Also provided are methods for regenerating muscle in a subject suffering from muscular atrophy, dystrophy, and/or injury by administering a PGE2 compound alone or in combination with isolated muscle cells. The PGE2 compound in combination with the isolated muscle cells can be administered prophylactically to prevent a muscle disease or condition.

Abstract: Provided herein are compositions for preventing or treating muscle conditions such as muscle damage, injury, or atrophy. In some embodiments, the compositions comprise a prostaglandin E2 (PGE2) compound and a myotoxin. In some embodiments, the muscle damage, injury, or atrophy is the result of a nerve injury, a surgical procedure, or a traumatic injury. Methods of promoting muscle regeneration and methods of increasing muscle mass are also provided herein.

Abstract: Systems and methods are provided for modeling electromagnetic properties of an assembly. The system includes a modeling component configured to divide the assembly into a plurality of subdomains, with each subdomain representing a three-dimensional volume of the assembly, and determine a set of standard elemental basis functions for each subdomain, such that a linear combination of elemental basis functions represents the electromagnetic properties of a portion of the geometry of the subdomain. A synthetic function generator is configured to generate a set of synthetic “entire-domain” basis functions for each subdomain from its set of elemental basis functions. A response characterization component is configured to determine the electromagnetic properties of the assembly from the sets of synthetic basis functions for each subdomain and an excitation matrix representing simulated incident electrical and magnetic stimulation to the assembly.

Abstract: Provided herein are compositions, methods, and kits for proliferating muscle cells by exposing the muscle cells to a prostaglandin E2 (PGE2) compound or compound that activates PGE2 signaling. Also provided are methods for regenerating muscle in a subject suffering from muscular atrophy, dystrophy, and/or injury by administering a PGE2 compound alone or in combination with isolated muscle cells. The PGE2 compound in combination with the isolated muscle cells can be administered prophylactically to prevent a muscle disease or condition.

Abstract: Provided herein are compositions, methods, and kits for proliferating muscle cells by exposing the muscle cells to a prostaglandin E2 (PGE2) compound or compound that activates PGE2 signaling. Also provided are methods for regenerating muscle in a subject suffering from muscular atrophy, dystrophy, and/or injury by administering a PGE2 compound alone or in combination with isolated muscle cells. The PGE2 compound in combination with the isolated muscle cells can be administered prophylactically to prevent a muscle disease or condition.

Abstract: Provided herein are compositions, methods, and kits for proliferating muscle cells by exposing the muscle cells to a prostaglandin E2 (PGE2) compound or compound that activates PGE2 signaling. Also provided are methods for regenerating muscle in a subject suffering from muscular atrophy, dystrophy, and/or injury by administering a PGE2 compound alone or in combination with isolated muscle cells. The PGE2 compound in combination with the isolated muscle cells can be administered prophylactically to prevent a muscle disease or condition.

Abstract: Provided herein are compositions, methods, and kits for proliferating muscle cells by exposing the muscle cells to a prostaglandin E2 (PGE2) compound or compound that activates PGE2 signaling. Also provided are methods for regenerating muscle in a subject suffering from muscular atrophy, dystrophy, and/or injury by administering a PGE2 compound alone or in combination with isolated muscle cells. The PGE2 compound in combination with the isolated muscle cells can be administered prophylactically to prevent a muscle disease or condition.

Abstract: Embodiments of the invention may provide for systems and methods for secure authentication. The systems and methods may include receiving, by a constrained device, a random string transmitted from a server; determining, by the constrained device, a responsive output by evaluating a first deterministic function based upon the received random string, a locally generated string and a first private key stored on the constrained device; and transmitting at least one portion of the responsive output and the locally generated string from the constrained device to a server.

Abstract: Embodiments of the invention may provide for systems and methods for secure authentication. The systems and methods may include receiving, by a constrained device, a random string transmitted from a server; determining, by the constrained device, a responsive output by evaluating a first deterministic function based upon the received random string, a locally generated string and a first private key stored on the constrained device; and transmitting at least one portion of the responsive output and the locally generated string from the constrained device to a server.

Abstract: This invention is directed to a method and system for generating and using digital fingerprints in copies of an electronic document so that it is possible to determine at least one from among a group of purchasers colluding to forge a digital fingerprint. The present method and system is suitable for copyright protection and can be used to identify purchasers who illegally redistribute copies even after the document has been manipulated.

Abstract: This invention is directed to a method and system for generating and using digital fingerprints in copies of an electronic document so that it is possible to determine at least one from among a group of purchasers colluding to forge a digital fingerprint. The present method and system is suitable for copyright protection and can be used to identify purchasers who illegally redistribute copies even after the document has been manipulated.